| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:Single-strain probiotic lactobacilli for the treatment of atopic dermatitis in children : a systematic review and meta-analysis
Avtorji:ID Fijan, Sabina (Avtor)
ID Kolč, Nina (Avtor)
ID Hrašovec, Metka (Avtor)
ID Jamtvedt, Gro (Avtor)
ID Šikić Pogačar, Maja (Avtor)
ID Mičetić-Turk, Dušanka (Avtor)
ID Maver, Uroš (Avtor)
Datoteke:.pdf Fijan-2023-Single-Strain_Probiotic_Lactobacill.pdf (2,43 MB)
MD5: 014422674D664259A8E2F5E9798D4AFC
 
URL https://doi.org/10.3390/pharmaceutics15041256
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:FZV - Fakulteta za zdravstvene vede
MF - Medicinska fakulteta
Opis:Probiotics are known for their positive effects on the gut microbiota. There is growing evidence that the infant gut and skin colonization have a role in the development of the immune system, which may be helpful in the prevention and treatment of atopic dermatitis. This systematic review focused on evaluating the effect of single-strain probiotic lactobacilli consumption on treating children's atopic dermatitis. Seventeen randomized placebo-controlled trials with the primary outcome of the Scoring Atopic Dermatitis (SCORAD) index were included in the systematic review. Clinical trials using single-strain lactobacilli were included. The search was conducted until October 2022 using PubMed, ScienceDirect, Web of Science, Cochrane library and manual searches. The Joanna Briggs Institute appraisal tool was used to assess the quality of the included studies. Meta-analyses and sub meta-analyses were performed using Cochrane Collaboration methodology. Due to different methods of reporting the SCORAD index, only 14 clinical trials with 1124 children were included in the meta-analysis (574 in the single-strain probiotic lactobacilli group and 550 in the placebo group) and showed that single-strain probiotic lactobacilli statistically significantly reduced the SCORAD index compared to the placebo in children with atopic dermatitis (mean difference [MD]: -4.50; 95% confidence interval [CI]: -7.50 to -1.49; Z = 2.93; p = 0.003; heterogeneity I-2 = 90%). The subgroup meta-analysis showed that strains of Limosilactobacillus fermentum were significantly more effective than strains of Lactiplantibacillus plantarum, Lacticaseibacillus paracasei or Lacticaseibacillus rhamnosus. A longer treatment time and younger treatment age statistically significantly reduced symptoms of atopic dermatitis. The result of this systematic review and meta-analysis shows that certain single-strain probiotic lactobacilli are more successful than others in reducing atopic dermatitis severity in children. Therefore, careful consideration to strain selection, treatment time and the age of the treated patients are important factors in enhancing the effectiveness of reducing atopic dermatitis in children when choosing probiotic single-strain lactobacilli.
Ključne besede:probiotics, lactobacilli, atopic dermatitis, children, meta-analysis, systematic review
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:03.03.2023
Datum sprejetja članka:14.04.2023
Datum objave:17.04.2023
Založnik:MDPI
Leto izida:2023
Št. strani:Str. 1-12
Številčenje:Letn. 15, Št. 4, št. članka 1256
PID:20.500.12556/DKUM-87088 Novo okno
UDK:616.5-002-053.2:613.292
COBISS.SI-ID:149693443 Novo okno
DOI:10.3390/pharmaceutics15041256 Novo okno
ISSN pri članku:1999-4923
Datum objave v DKUM:16.02.2024
Število ogledov:696
Število prenosov:172
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Pharmaceutics
Skrajšan naslov:Pharmaceutics
Založnik:MDPI
ISSN:1999-4923
COBISS.SI-ID:517949977 Novo okno

Gradivo je financirano iz projekta

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0036
Naslov:Bio-psiho-socialni model kvalitete življenja

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:L7-4494
Naslov:Kompleksen in vitro model kože z vključeno plastjo kosti za testiranje ne-invazivnega glukoznega senzorja

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J3-1762
Naslov:Nov inovativen pristop k zdravljenju pleničnega izpuščaja z uporabo plenic z vgrajenimi probiotičnimi bakterijami

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:17.04.2023

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:probiotiki, laktobacili, atopijski dermatitis, otroci, meta analiza, sistematični pregled


Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici